HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care Selected Research

Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care Research Topics

Disease

4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2006 - 12/2005
3Neoplasms (Cancer)
11/2006 - 12/2005
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2007 - 02/2004
2Malignant Mesothelioma
07/2006 - 07/2006
1Thrombocytopenia (Thrombopenia)
04/2007
1Anemia
04/2007
1Diarrhea
04/2007
1Febrile Neutropenia
11/2006
1Disease Progression
05/2006

Drug/Important Bio-Agent (IBA)

4Cisplatin (Platino)FDA LinkGeneric
04/2007 - 02/2004
2Etoposide (VP 16)FDA LinkGeneric
04/2007 - 02/2004
2Carboplatin (JM8)FDA LinkGeneric
04/2007 - 12/2005
2Gefitinib (Iressa)FDA Link
11/2006 - 05/2006
2Docetaxel (Taxotere)FDA Link
11/2006 - 12/2005
1Topotecan (Hycamtin)FDA LinkGeneric
04/2007
1Pemetrexed (MTA)FDA Link
07/2006
1ErbB Receptors (EGF Receptor)IBA
05/2006
1Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2006
1PlatinumIBA
05/2006
1Taxoids (Taxanes)IBA
12/2005
1taxaneIBA
12/2005
1GemcitabineFDA Link
12/2005
1Paclitaxel (Taxol)FDA LinkGeneric
12/2005
1Vinorelbine (Navelbine)FDA LinkGeneric
12/2005

Therapy/Procedure

5Drug Therapy (Chemotherapy)
04/2007 - 02/2004
4Therapeutics
11/2006 - 12/2005
2Radiotherapy
07/2006 - 02/2004
2Combination Drug Therapy (Combination Chemotherapy)
12/2005 - 02/2004
1Oral Administration
04/2007
1Contraindications
12/2005
1Duration of Therapy
02/2004